跳至主要内容
临床试验/NCT01360060
NCT01360060已完成不适用

Analgesia After Cesarean Section

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 503 人开始时间: 2010年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
503
试验地点
1
主要终点
Change of numeric rating scale (NRS) of postoperative pain during postoperative period

研究概览

简要总结

Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • parturients undergoing Cesarean section

排除标准

  • 未提供

研究组 & 干预措施

Group P

parturients who had undergone Cesarean section under the diagnosis of preeclampsia

干预措施: Magnesium Sulphate (Drug)

结局指标

主要结局

Change of numeric rating scale (NRS) of postoperative pain during postoperative period

时间窗: postoperative 1, 2, 3, and 4 day

次要结局

  • incidence of stopping of intravenous PCA during postoperative 4 days(during postoperative 4 days)
  • serum magnesium level of group P(preoperative 1 h and postoperative 1 day)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验